Taiwan - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Taiwan Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry grew 3.5% year on year. At $581,419,961.53 Million PPP in 2019, the country was number 13 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Taiwan is overtaken by Sweden, which was ranked number 12 with $847,585,097.1 Million PPP and is followed by United Kingdom with $542,693,029.31 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, a growth of 3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 581,419,961.53 |
| 2018 | 542,268,283.84 |
| 2017 | 567,625,176.16 |
| 2016 | 557,535,648.27 |
| 2015 | 456,819,170.68 |
How does Taiwan rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 12 |
#12
Sweden
|
847,585,097.10 | 2019 | -0.1 % | +2.1 % | View data | |
| 13 |
#13
Taiwan
|
581,419,961.53 | 2019 | +7.2 % | +3.5 % | View data | |
| 14 |
#14
United Kingdom
|
542,693,029.31 | 2019 | -1.0 % | -1.1 % | View data | |